Minimum import price floor extended on key pharmaceutical raw materials

The Directorate General of Foreign Trade (DGFT) has extended Minimum Import Price (MIP) restrictions on two active pharmaceutical ingredients, ATS-8 and Sulfadiazine API. The price floor prevents foreign dumping, curbs under-invoicing, and protects domestic bulk drug manufacturing capacity.

Join our 1500+ subscribers to get our daily Health Laws and Policy Updates.